Floatz logo

Endostar

Angiogenesis

Fujian Cancer Hospitalprotein_peptidePhase 3Dormant
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
95/ 100

Competitive context

4 Active assets in the Angiogenesis cohort.

Asset / SponsorPhaseRating
Erythropoietin Human Recombinant
Ajou University School of Medicine
Phase 2BB
Carboplatin
Wenjun Cheng
Phase 3BB
Catequentinib
Wenjun Cheng
Phase 2BB
Olaparib
Xiaoxiang Chen
Phase 2CCC
(+)-VINCRISTINE
Xiaoxiang Chen
Phase 2CCC

View all 11 →

Same molecule, other indications

Endostar is also rated in:

non-small cell lung carcinomaDormant
BB
Indicative ·
70 / 100
View asset →
colorectal neoplasmDormant
B
Indicative ·
63 / 100
View asset →
Leptomeningeal MetastasisDormant
B
Indicative ·
62 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →